Scientists Studied 678 Nuns for Decades. What They Found Changed Dementia Research Forever
The Nun Study is back in the spotlight after a 2025 scientific review revisited its findings on aging, Alzheimer’s and dementia. Here’s what to know about the 30-year project that followed 678 Catholic sisters and rewrote how researchers understand the aging brain.
What Is the Nun Study and Why Does It Matter for Dementia Research?
The Nun Study is a landmark longitudinal investigation of aging and Alzheimer’s disease that began in 1990 with 678 sisters from the School Sisters of Notre Dame, funded through the National Institute on Aging.
David Snowdon, Ph.D., launched a pilot in 1986 to examine how education and lifestyle shaped aging-related disorders, then expanded the work into a full study of sisters across the United States. Participants agreed to annual cognitive and physical assessments, gave researchers access to convent archives and medical records and consented to brain donation at death. Most participants were 75 to 102 years old at enrollment. Although all of the participating sisters have since died, their donated brain tissue continues to fuel new findings, the congregation says on its website.
Who Were the 678 Nuns in the Study?
The participants were members of the School Sisters of Notre Dame, a congregation originally founded in Bavaria to teach girls. Of 1,027 eligible sisters, 678 (66%) agreed to join.
Researchers chose the community because the women had lived remarkably similar lives, sharing comparable housing, nutrition and healthcare, along with similar occupations and social environments. About 85% had earned at least a bachelor’s degree, and 89% had worked as teachers. That uniformity stripped away many of the confounding lifestyle differences that complicate other epidemiological studies. “It is difficult to find a community of people with such consistent and comparable lifestyles,” Kyra Clarke, a doctorate student at UT Health San Antonio, told EWTN News. “This makes it easier to figure out what factors truly increase or decrease the risk of dementia.”
What Did the Nun Study Reveal About Alzheimer’s Disease?
The nun study reshaped how scientists think about Alzheimer’s by showing that brain pathology and cognitive symptoms don’t always line up. Some sisters had significant amyloid plaques and neurofibrillary tangles at autopsy yet never developed dementia during their lives.
Researchers also found that early-life cognitive ability, measured through autobiographies written in young adulthood and educational records, was linked to better cognitive outcomes decades later, according to a 2025 scientific review published in Alzheimer’s & Dementia. Those findings helped establish the concept of cognitive reserve, the idea that lifelong mental engagement may protect thinking and memory even when disease is present in the brain. The study also showed that multiple brain diseases often coexist in older adults and that overlapping pathologies raise dementia risk.
How Did Nutrition Factor Into the Nun Study Findings?
The nun study linked folate levels to brain health in aging. Sisters with lower blood folate, or vitamin B9, tended to show greater brain shrinkage and weaker cognitive performance than those with higher levels.
Low folate concentrations, particularly when paired with elevated homocysteine, were associated with an increased likelihood of Alzheimer’s disease and cognitive impairment. The findings did not prove folic acid prevents dementia, but they pointed to adequate folate status as a meaningful piece of healthy brain aging. By the study’s end, 98% of participants had undergone brain autopsy, and more than 600 brains were examined by neuropathologists who were blinded to the sisters’ cognitive test results. That method let researchers directly compare in-life memory and thinking scores with what was actually happening inside the brain.
Why Do Researchers Still Talk About the Nun Study Today?
Researchers still cite the nun study because it changed the paradigm for how scientists think about aging and Alzheimer’s disease. “The Nun Study has certainly been pioneering,” Dr. Richard Suzman, chief of demography and population epidemiology at the National Institute on Aging, told The New York Times. “It’s helped change the paradigm about how people think about aging and Alzheimer’s disease.”
Dr. Robert P. Friedland, professor of neurology at Case Western Reserve University, told the Times the work was crucial because it captured information about participants long before illness began. “So we know from the Nun Study and others that Alzheimer’s disease takes several decades to develop, and the disease has many important effects on all aspects of a person’s life,” he said. Margaret Flanagan now directs the ongoing research at UT Health, and neuropathology investigations on the donated brains continue.
This article was created by content specialists using various tools, including AI.
